VIENNA -- Today Lexogen, the transcriptomics and next-generation sequencing company, announced that Stéphane Barges, PhD, MBA has been appointed as new Chief Executive Officer effective from September 1, 2020. Stéphane Barges of Lexogen Dr. Barges said "Lexogen is already a renowned company thanks to the quality of its very innovative products and of its customer support [...]

WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today confirmed that its offer to acquire all of QIAGEN's ordinary shares for an increased price of €43.00 per share in cash will expire at 24:00 hours (Frankfurt am Main local time) / 18:00 hours (New York local time) on [...]

Nacka, Sweden, August 4, 2020: Atlas Copco has acquired the technology and operating assets of iTrap. The iTrap is an ion trap mass spectrometer instrument capable of highly sensitive real time gas analysis. The instrument is used for diagnostics or process control in semiconductor process chambers. The business is located in Oberkochen, in southern Germany, [...]

SAN JOSE, Calif. -- Loop Genomics has come one step closer to replacing Sanger sequencing with NGS. Loop's new product enables massively parallel multiplexing of colonies and cloned DNA's into a single tube and sequencing them on NGS instruments, reducing the time and cost of sequencing cloned DNA. "The decades old practice of sequencing amplicons from colonies is still prohibitively [...]

Long-time Chairman to retire AUSTIN, Texas -- Luminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, G. Walter Loewenbaum, from its Board of Directors ("Board") effective August 3, 2020. "On behalf of Luminex's shareholders and Board, I would like to thank Wally for his invaluable service and contributions to Luminex for over 25 years," said Nachum 'Homi' [...]

Manchester, UK: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group, today announces a proposed placing (the "Placing") of new ordinary shares of 0.1 pence each ("Ordinary Shares") in the capital of the Company (the "Placing Shares") at a price of 17 pence per share (the "Placing Price") to raise a minimum of £13 million. The [...]

HERCULES, Calif. –Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the The United States Court of Appeals for the Federal Circuit today affirmed that 10x Genomics willfully infringed U.S. Patent 8,889,083, exclusively licensed to Bio-Rad from the University of Chicago. The Appeals Court upheld [...]

Partnership enables biopharma developers to increase efficiency and bring safe, effective drugs to market SCIEX, a global leader in life science analytical technologies, and 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announce the general availability of the ZipChip® platform on SCIEX mass spectrometers (MS). With this release, SCIEX expands its suite [...]

Smiths Detection, a global leader in detection and screening technologies, today confirmed that it has completed the acquisition of PathSensors, a leading bio-technology solutions and environmental-testing company, based in Baltimore, MD, USA. The acquisition strengthens Smiths Detection’s biological-detection capabilities to detect pathogens for broad end-market applications, including in food and agriculture safety. “We are pleased [...]

CRISPR-based screening technology platform to address critical gaps in target ID and validation Single cell RNAseq-linked pooled CRISPR screening offers high-quality screening data and biological insight Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Company", or "the Group"), a global leader in the application of gene editing and gene modulation for cell line engineering, [...]